What’s Next for the Biotech Bull Market? Are You a Trader or an Investor? Update-2 Sell-Off
Momentum Continues 5/29...We will update the coronavirus trade tomorrow so sign up! Today the market recovered (NAZ up 1.4%) after Trump's rant against China. With no new news like tariffs it's back to "don't fight the tape, don't fight the FED". Its ASCO time so this should be positive for...
Coronavirus Stock Portfolio: Biotech remains strong and the need for a COVID vaccine dominates the news-Update-3
Race to Develop a Coronavirus Vaccine Has $BB Funding with Several Major Players Update-3 5/20...Reversal to upside from yesterday's sell-off. However the cynics are starting to come out questioning the timelines of some of the major COVID vaccine players with high valuations at such an early...
Recap on Coronavirus Focus Stock Performance Q1 2020…May 11…Biotech Rally Broadens
5/11/20 330p EDT Crazy market running up again in healthcare, life sciences and biotech; cyclicals continue to lag. XBI break-out to new highs at $104 up 4.7%. IBB up 3.94% to $133. This run reminds me of JY 2015 last big blowoff and speculative frenzy. But small cap ETFs lag: IJR, XLV up...
Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains-Update-2 Rotation day
Update-2 4/29 12:15p Mid-day trading -Healthcare weak as Investors rebalance to other sectors. Gilead Sciences (GILD) up over 6% and. boosts overall market with positive remdesivir data. NAZ up 2.84%, IBB up 1.3%, IJR break-out? Technology, financials and energy show big gains; rally broadening...
Volatile Coronavirus Stock Plays-Update and Summary April 23 GILD ?
Coronavirus (COVID-19) is an infectious disease currently spreading across the globe. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover. Others (particularly elderly people and those with underlying medical problems) are more likely to...